Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  Childs: []
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377794
    value: Clinical group
  ExternalReferences:
  - DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
      to represent it)
    Reference: '607948'
    Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences: []
      Name: solute carrier family 11 member 1
      Symbol: SLC11A1
  Label: Tuberculosis
  ORPHAcode: '3389'
  ORPHApacketId: '3389'
  PURL: http://www.orpha.net/ORDO/Orphanet_3389
  Parents:
  - Parent:
    - Label: Rare bacterial infectious disease
      ORPHAcode: '163582'
  - Parent:
    - Label: Disease associated with a genetic susceptibility or tested for a biomarker
      ORPHAcode: '231957'
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Israel
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 6-9 / 10 000
      PrevalenceGeographic: Algeria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Bosnia and Herzegovina
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: '>1 / 1000'
      PrevalenceGeographic: Romania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 6-9 / 10 000
      PrevalenceGeographic: Russian Federation
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: '>1 / 1000'
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21420560[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: Centers for Disease Control and Prevention 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Hungary
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: '>1 / 1000'
      PrevalenceGeographic: India
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 6-9 / 10 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Latin America
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: '>1 / 1000'
      PrevalenceGeographic: South Africa
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 6-9 / 10 000
      PrevalenceGeographic: Ukraine
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: World Health Organization 2011[INST]
      ValMoy: no data
  TextSection:
    Contents: Tuberculosis (TB) is a contagious-infectious disease caused mainly by
      <i>Mycobacterium tuberculosis</i> that in most individuals is usually asymptomatic
      but that in at risk individuals (e.g. with diabetes or with HIV infection) can
      cause weakness fever weight loss night sweat and respiratory anomalies such
      as chronic cough chest pain hemoptysis or respiratory insufficiency.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2023
  creationDate: '2023-12-06 11:51:54'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
